These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors. Tränkle C, Mohr K. Mol Pharmacol; 1997 Apr; 51(4):674-82. PubMed ID: 9106634 [Abstract] [Full Text] [Related]
13. Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation. Jakubík J, Tucek S. Br J Pharmacol; 1994 Dec; 113(4):1529-37. PubMed ID: 7889311 [Abstract] [Full Text] [Related]
14. Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium. Jakubík J, Tucek S. J Neurochem; 1994 Nov; 63(5):1932-40. PubMed ID: 7931349 [Abstract] [Full Text] [Related]
19. Potentiation by alcuronium of the antimuscarinic effect of N-methylscopolamine in guinea pig left atria. Maass A, Kostenis E, Mohr K. Eur J Pharmacol; 1995 Jan 05; 272(1):103-6. PubMed ID: 7713140 [Abstract] [Full Text] [Related]
20. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. Flynn DD, Vaishnav AA, Mash DC. Mol Pharmacol; 1992 Apr 05; 41(4):736-42. PubMed ID: 1569924 [Abstract] [Full Text] [Related] Page: [Next] [New Search]